CPMI-1023 -Sequence # 15510 | Conditional History - Cancer-1023 -Sequence # 15510

Video Transcription

Video Summary

In this video, the June 2023 case scenario is reviewed, specifically focusing on P2Y12 inhibitors at discharge. The video discusses the functionality of metric 46 within the eReports dashboard executive summary, providing steps to understand and evaluate metric feedback. The scenario involves a 64-year-old female patient with chest tightness and abdominal pain, who had a stent placed six months prior. The patient is taken to the cardiac cath lab, where no changes are observed from the previous angiogram. The physician continues prescribing aspirin and increases the dose of libetalol. Due to cost concerns, the patient's current prescription of Prazugrel is continued instead of clopidogrel and ticagrelor. The video poses questions and provides answers related to coding discharge medication and displaying patient data in metric 46. It emphasizes referring to the Executive Summary Measures and Metric Companion Guide for understanding and interpreting metrics. The final conclusion states that the patient's case qualifies as a denominator exception in metric 46 due to medical reasons for not receiving clopidogrel and ticagrelor. The video concludes by thanking the viewer for reviewing the case scenario. No credits are provided.

Keywords

June 2023 case scenario

P2Y12 inhibitors at discharge

metric 46

eReports dashboard executive summary

64-year-old female patient